Roctavian

Hand scales with money and drugs
Special Reports

UPDATED: Most expensive drugs in the US in 2025

One-dose gene therapies with multimillion-dollar price tags make up the top 10 most expensive drugs in the U.S.
BioMarin building

BioMarin unveils strategic redesign under CEO Alexander Hardy

Sep 4, 2024 5:32pm
layoffs

BioMarin lays off 225 more staffers under new corporate strategy

Aug 29, 2024 4:30am
Shanbally

BioMarin downsizes gene therapy efforts to focus on 3 markets

Aug 6, 2024 10:34am
Graphic of a fork in the road with arrows pointing in either direction

With slow sales, BioMarin weighs Roctavian divestiture

Apr 29, 2024 11:51am
Biomarin

BioMarin’s commercial chief Jeffrey Ajer hits the exit

Jan 12, 2024 10:28am